The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs: APP splicing is regulated by microRNAs
Abstract
The β-amyloid peptide that accumulate in Alzheimer's disease (AD) brain derive from proteolytic processing of the amyloid precursor protein (APP). Recent evidence suggest that microRNAs (miRNAs) participate in the post-transcriptional regulation of APP expression. Because gene dosage effects of the APP gene can cause genetic AD, dysregulation of the miRNA network could contribute significantly to disease. Here, we present evidence that, besides APP expression regulation, miRNAs are equally involved in the regulation of neuronal APP mRNA alternative splicing. Lack of miRNAs in post-mitotic neurons in vivo is associated with APP exons 7 and 8 inclusion, while ectopic expression of miR-124, an abundant neuronal-specific miRNA, reversed these effects in cultured neurons. Similar results were obtained by depletion of endogenous polypyrimidine tract binding protein 1 (PTBP1) in cells, a recognized miR-124 target gene. Furthermore, PTBP1 levels correlate with the presence of APP exons 7 and 8, while PTBP2 levels correlate with the skipping of these exons during neuronal differentiation. Finally, we show that miR-124 is down-regulated in AD brain. In sum, our results suggest that specific miRNAs are involved in the fine-tuning of APP alternative splicing in neurons. Since abnormal neuronal splicing of APP affects β-amyloid peptide production, these results could contribute to the understanding of the implication of miRNAs in brain health and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
miR-124 and miR-107 are downregulated in AD brains.
“Smith et al. [59] found that miR-124 and miR-107 were downregulated in AD brains”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [59]
miR-9-5p, miR-16-5p, miR-29b, miR-124 and miR-206-3p were related to the generation of Aβ.
“miR-9-5p [42,43], miR-16-5p [101], miR-29b [47], miR-124 [59] and miR-206-3p [105] were related to the generation of Aβ.”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [59]
Citations
Cites
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943
Alterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452
Self-citationMicroRNA regulation of Alzheimer's Amyloid precursor protein expression
Hébert, S. S., Horré, K., Nicolaï, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., & De Strooper, B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.009 · Cited by 436
Self-citationMicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development
Boutz, P. L., Chawla, G., Stoilov, P., & Black, D. L. (2007) · Genes & Development · doi:10.1101/gad.1500707 · Cited by 304
Flagged first, then by citations
Research works printed but not linked: 30
- Bendotti, 1988, Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned mice, Proc. Natl Acad. Sci. USA, 85, 3628, 10.1073/pnas.85.10.3628 · DOI
- Bergmans, 2010, Neurons generated from APP/APLP1/APLP2 triple knockout embryonic stem cells behave normally in vitro and in vivo: lack of evidence for a cell autonomous role of the amyloid precursor protein in neuronal differentiation, Stem Cells, 28, 399, 10.1002/stem.296 · DOI
- Bergsdorf, 2000, Identification of cis-elements regulating exon 15 splicing of the amyloid precursor protein pre-mRNA, J. Biol. Chem., 275, 2046, 10.1074/jbc.275.3.2046 · DOI
- Conaco, 2006, Reciprocal actions of REST and a microRNA promote neuronal identity, Proc. Natl Acad. Sci. USA, 103, 2422, 10.1073/pnas.0511041103 · DOI · Paper page
- De Strooper, 2010, Novel research horizons for presenilins and gamma-secretases in cell biology and disease, Annu. Rev. Cell Dev. Biol., 26, 235, 10.1146/annurev-cellbio-100109-104117 · DOI
- Donev, 2007, A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms, Mol. Psychiatry, 12, 681, 10.1038/sj.mp.4001971 · DOI
- Fan, 2010, miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells, Acta Biochim. Biophys. Sin. (Shanghai), 42, 318, 10.1093/abbs/gmq026 · DOI
- Golde, 1990, Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR, Neuron, 4, 253, 10.1016/0896-6273(90)90100-T · DOI
- Hebert, 2006, Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes, EMBO Rep., 7, 739, 10.1038/sj.embor.7400704 · DOI
- Hebert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression, Proc. Natl Acad. Sci. USA, 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
- Hebert, 2010, Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration, Hum. Mol. Genet., 19, 3959, 10.1093/hmg/ddq311 · DOI
- Jacobsen, 1991, Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer’s disease and normal brain by S1 nuclease protection analysis, Neurobiol. Aging, 12, 585, 10.1016/0197-4580(91)90090-7 · DOI
- Kalsotra, 2010, MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development, Genes Dev., 24, 653, 10.1101/gad.1894310 · DOI · Paper page
- Lim, 2005, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature, 433, 769, 10.1038/nature03315 · DOI · Paper page
- Liu, 2010, MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer’s-associated pathogenesis in SAMP8 mice, Neurobiol. Aging
- Lukiw, 2007, Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus, Neuroreport, 18, 297, 10.1097/WNR.0b013e3280148e8b · DOI · Paper page
- Makeyev, 2008, Multilevel regulation of gene expression by microRNAs, Science, 319, 1789, 10.1126/science.1152326 · DOI
- Makeyev, 2007, The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing, Mol. Cell, 27, 435, 10.1016/j.molcel.2007.07.015 · DOI · Paper page
- Menendez-Gonzalez, 2005, APP processing and the APP-KPI domain involvement in the amyloid cascade, Neurodegener. Dis., 2, 277, 10.1159/000092315 · DOI
- Nelson, 2010, MiR-107 is reduced in Alzheimer’s disease brain neocortex: validation study, J. Alzheimers Dis., 21, 75, 10.3233/JAD-2010-091603 · DOI · Paper page
- Neve, 1990, The Alzheimer amyloid precursor-related transcript lacking the beta/A4 sequence is specifically increased in Alzheimer’s disease brain, Neuron, 5, 329, 10.1016/0896-6273(90)90169-G · DOI
- Nunez-Iglesias, 2010, Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer’s disease cortex reveals altered miRNA regulation, PLoS ONE, 5, 10.1371/journal.pone.0008898 · DOI
- Papagiannakopoulos, 2009, MicroRNA-124: micromanager of neurogenesis, Cell Stem Cell, 4, 375, 10.1016/j.stem.2009.04.007 · DOI
- Patel, 2008, MicroRNAs can regulate human APP levels, Mol. Neurodegener., 3, 10.1186/1750-1326-3-10 · DOI
- Poleev, 2000, A trans-acting factor, isolated by the three-hybrid system, that influences alternative splicing of the amyloid precursor protein minigene, Eur. J. Biochem., 267, 4002, 10.1046/j.1432-1327.2000.01431.x · DOI
- Rockenstein, 1995, Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer’s disease, J. Biol. Chem., 270, 28257, 10.1074/jbc.270.47.28257 · DOI
- Shioya, 2010, Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neuron navigator-3, Neuropathol. Appl. Neurobiol., 36, 320, 10.1111/j.1365-2990.2010.01076.x · DOI · Paper page
- Tanzi, 1993, Cellular specificity and regional distribution of amyloid beta protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation, Brain Res. Mol. Brain Res., 18, 246, 10.1016/0169-328X(93)90196-V · DOI
- Vilardo, 2010, MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons, J. Biol. Chem., 285, 18344, 10.1074/jbc.M110.112664 · DOI
- Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1, J. Neurosci., 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
Cited by
Sorted by citations
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
An updated role of microRNA-124 in central nervous system disorders: a review
Sun, Y., Luo, Z.-M., Guo, X.-M., Su, D.-F., & Liu, X. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00193 · Cited by 223
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
Long, J. M., Ray, B., & Lahiri, D. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518241 · Cited by 187
Genomic integrity and the ageing brain
Chow, H.-M., & Herrup, K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4020 · Cited by 174
Chivero, E. T., Liao, K., Niu, F., Tripathi, A., Tian, C., Buch, S., & Hu, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00573 · Cited by 69
miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases
Xu, J., Zheng, Y., Wang, L., Liu, Y., Wang, X., Li, Y., & Chi, G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01091-6 · Cited by 55
MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease
Li, W., & Zheng, Y. (2023) · Cells · doi:10.3390/cells12101378 · Cited by 43
Metadata
- Authors
- Smith, P., Al Hashimi, A., Girard, J., Delay, C., & Hébert, S. S.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2010-12-02
- Volume
- 116
- Issue
- 2
- Pages
- 240-247
- ISSN
- 0022-3042
- Cited by
- 182
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review